AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GABAPENTIN 400 Mg ;
11 registrations across 1 African market— 11 active
Markets with GABAPENTIN 400 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Gabaverona 400 mg Hard Gelatin Capsules | 🇪🇬Egypt | AVERROES PHARMA for pharmaceutical industries | active | — |
| Enhantin 400 mg Hard Gelatin Capsules | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| Gabaverona 400 mg Hard Gelatin Capsules | 🇪🇬Egypt | AVERROES PHARMA for pharmaceutical industries | active | — |
| Manipulepsy Hard Gelatin Capsules | 🇪🇬Egypt | Gypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTO | active | — |
| Gabroxia Hard Gelatin Capsules | 🇪🇬Egypt | PharmaStars Pharmaceuticals | active | — |
| Epicopentin 400mg Hard Gelatin Capsules | 🇪🇬Egypt | Egyptian International Pharmaceutical Industries Company (EIPICO) | active | — |
| Enhantin 400 mg Hard Gelatin Capsules | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| Sajalipsy 400mg Hard Gelatin Capsules | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
| Manipulepsy Hard Gelatin Capsules | 🇪🇬Egypt | Gypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTO | active | — |
| Epicopentin 400mg Hard Gelatin Capsules | 🇪🇬Egypt | Egyptian International Pharmaceutical Industries Company (EIPICO) | active | — |
| Gabroxia Hard Gelatin Capsules | 🇪🇬Egypt | PharmaStars Pharmaceuticals | active | — |
GABAPENTIN 400 Mg ; in Africa — Regulatory Overview
GABAPENTIN 400 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.